Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: A new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA

Journal of Immunological Methods

Volumn 356, Issue 1-2, 2010, Pages 39-46

  Mbisa, Georgina L ^a   Miley, Wendell ^a   Gamache, Christine J ^a   Gillette, William K ^a   Esposito, Dominic ^a   Hopkins, Ralph ^a   Busch, Michael P ^b,c   Schreiber, George B ^d   Little, Richard F ^e   Yarchoan, Robert ^e   Ortiz Conde, Betty A ^a   Labò, Nazzarena ^a   Whitby, Denise ^a  

^a SAIC FREDERICK INC   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WESTAT   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ELISA; K8.1; KSHV serology; LANA

Indexed keywords

LATENCY ASSOCIATED PEPTIDE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; VIRUS ANTIGEN;

ALGORITHM; ANTIBODY DETECTION; ANTIGEN PURIFICATION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; KAPOSI SARCOMA; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY; ANIMAL; ARMYWORM; BLOOD; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; HERPES VIRUS INFECTION; IMMUNOLOGY; METHODOLOGY; REPRODUCIBILITY;

HUMAN HERPESVIRUS 8; MAMMALIA;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SARCOMA, KAPOSI; SPODOPTERA;

EID: 77951633221     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.02.015     Document Type: Article

References (27)

1. Biggar R.J., Engels E.A., Whitby D., et al. Antibody reactivity to latent and lytic antigens to Human herpesvirus-8 in longitudinally followed homosexual men. J. Infect. Dis. 2003, 187:12.
2. Cesarman E., Chang Y., Moore P.S., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332:1186.
3. Chandran B., Smith M.S., Koelle D.M., et al. Reactivities of human sera with Human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 1998, 243:208.
4. Chang Y., Cesarman E., Pessin M.S., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865.
5. de Sanjosé S., Marshall V., Solà J., et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int. J. Cancer 2002, 98(1):155.
6. Engels E.A., Sinclair M.D., Biggar R.J., et al. Latent class analysis of Human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta. Int. J. Cancer 2000, 88:1003.
7. Engels E.A., Whitby D., Goebel P.B., et al. Identifying Human herpesvirus 8 infection: performance characteristics of serologic assays. J. Acquir. Immune Defic. Syndr. 2000, 23:346.
8. Gao S.J., Kingsley L., Li M., Zheng W., et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 1996, 2:925.
9. Kedes D.H., Lagunoff M., Renne R., et al. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 1997, 100:2606.
10. Kedes D.H., Operskalski E., Busch M., et al. The seroepidemiology of Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 1996, 2:918.
11. Kellam P., Boshoff C., Whitby D., et al. Identification of a major latent nuclear antigen, LNA-1, in the Human herpesvirus 8 genome. J. Hum. Virol. 1997, 1:19.
12. Kellam P., Bourboulia D., Dupin N., et al. Characterization of monoclonal antibodies raised against the latent nuclear antigen of Human herpesvirus 8. J. Virol. 1999, 73:5149.
13. Lam L.L., Pau C.P., Dollard S.C., et al. Highly sensitive assay for Human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J. Clin. Microbiol. 2002, 40:325.
14. Laney A.S., Peters J.S., Manzi S.M., et al. Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J. Clin. Microbiol. 2006, 44:3734.
15. Lennette E.T., Blackbourn D.J., Levy J.A. Antibodies to Human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348:858.
16. Minhas V., Crosby N.L., Crabtree K.L., et al. Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of Human herpesvirus 8-specific antibodies. Clin. Vacc. Immunol. 2008, 15(8):1259.
17. Nascimento M.C., de Souza V.A., Sumita L.M., et al. Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis. J. Clin. Microbiol. 2007, 45:715.
18. Olsen S.J., Sarid R., Chang Y., Moore P.S. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J. Infect Dis. 2000, 182:306.
19. Pellett P.E., Wright D.J., Engels E.A., et al. Multicenter comparison of serologic assays and estimation of Human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003, 43:1260.
20. Raab M.S., Albrecht J.C., Birkmann A., et al. The immunogenic glycoprotein gp35-37 of Human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 1998, 72:6725.
21. Rabkin C.S., Schulz T.F., Whitby D., et al. Interassay correlation of Human herpesvirus 8 serologic tests. HHV-8 interlaboratory collaborative group. J. Infect. Dis. 1998, 178:304.
22. Rainbow L., Platt G.M., Simpson G.R., et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 1997, 71:5915.
23. Simpson G.R., Schulz T.F., Whitby D., et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133.
24. Soulier J., Grollet L., Oksenhendler E., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276.
25. Whitby D., Howard M.R., Tenant-Flowers M., et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799.
26. Zhu L., Puri V., Chandran B. Characterization of Human herpesvirus-8K8.1A/B glycoproteins by monoclonal antibodies. Virology 1999, 262:237.
27. Zuck T.F., Thomson R.A., Schreiber G.B., et al. The retrovirus epidemiology donor study (REDS): rationale and methods. Transfusion 1995, 35:944.